Antiviral Drugs - United Kingdom

United Kingdom

The Antiviral Drugs market in the United Kingdom is expected to witness a significant growth in revenue, projected to reach €1.18bn in 2024.
Furthermore, the market is anticipated to display a steady annual growth rate (CAGR 2024-2029) of 2.88%.
As a result, the market volume is estimated to reach €1.36bn by 2029.
In a global context, United States is expected to generate the highest revenue in the Antiviral Drugs market, with a staggering €28,420.00m in 2024.
The United Kingdom's antiviral drug market is experiencing a surge in demand due to the ongoing COVID-19 pandemic.

Key regions: Brazil, India, Australia, United States, United Kingdom

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Antiviral Drugs market in United Kingdom has been steadily growing in recent years, driven by several factors that have increased demand for these medications.

Customer preferences: Antiviral drugs are used to treat viral infections, including HIV, hepatitis, and influenza. In the UK, there is a high demand for these drugs due to the prevalence of these diseases. Additionally, the COVID-19 pandemic has further increased demand for antiviral drugs, as researchers work to develop effective treatments for the virus.

Trends in the market: One major trend in the Antiviral Drugs market in United Kingdom is the increasing use of combination therapies. This involves using multiple antiviral drugs to treat a single infection, which can be more effective than using a single drug. Another trend is the development of new antiviral drugs, which are more effective and have fewer side effects than older medications. These new drugs are also more expensive, which has driven up the overall cost of the market.

Local special circumstances: The UK has a well-established healthcare system, which has helped to drive demand for antiviral drugs. Additionally, the country has a high prevalence of viral infections, which has further increased demand. The UK is also home to several large pharmaceutical companies that develop and manufacture antiviral drugs, which has helped to support the growth of the market.

Underlying macroeconomic factors: The Antiviral Drugs market in United Kingdom is also influenced by broader macroeconomic factors. For example, the cost of healthcare in the UK is rising, which has put pressure on healthcare providers to find more cost-effective treatments. Additionally, the UK is facing an aging population, which is increasing demand for healthcare services overall. These factors are likely to continue driving growth in the Antiviral Drugs market in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.